title: Defining antibody targets in Streptococcus oralis infection.
abstract: Immunoblotting of sera from 12 neutropenic patients with Streptococcus oralis septicemia and 18 patients with endocarditis due to viridans group streptococci revealed immunodominant S. oralis antigens at 85 and 180 kDa. The former cross-reacted with a mouse monoclonal antibody to hsp90. The latter was identified by sequencing positive clones obtained by screening a genomic expression library of S. oralis with pooled sera from patients who had been infected with S. oralis. Antibody eluted from one of these clones reacted with the 180-kDa antigen of S. oralis. Southern blotting confirmed the origin of the clone from S. oralis. The derived amino acid sequence showed 76.2% homology with the PAc protein precursor of Streptococcus mutans and 73.8% homology with the SpaA protein precursor of Streptococcus sobrinus. Epitope mapping of the derived amino acid sequence with sera from patients with viridans group streptococcal endocarditis delineated nine epitopes. Peptides 1 (TMYPNRQPGSGWDSS) and 2 (WYSLNGKIRAVDVPK), representing two of these epitopes, and peptide 3 (YEVEKPLEPAPVAPS), representing the repeat proline region, were synthesized. These three peptides were used to screen a phage antibody display library derived from a patient who had recovered from S. oralis infection. Two of the human recombinant antibodies produced (SORAL 3 and SORAL 4 against peptide 3) and a human recombinant antibody (B3.7) against the conserved epitope (LKVIRK) of hsp90 gave statistically significant protection, compared with control groups, in a mouse model of lethal S. oralis infection.
authors.affiliation: University Department of Medical Microbiology, Manchester Healthcare Trust, United Kingdom.
authors.forename: J P
authors.initials: JP
authors.lastname: Burnie
authors.forename: W
authors.initials: W
authors.lastname: Brooks
authors.forename: M
authors.initials: M
authors.lastname: Donohoe
authors.forename: S
authors.initials: S
authors.lastname: Hodgetts
authors.forename: A
authors.initials: A
authors.lastname: al-Ghamdi
authors.forename: R C
authors.initials: RC
authors.lastname: Matthews
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial / Q000235:genetics; D001428:Bacterial Vaccines / Q000235:genetics / Q000494:pharmacology; D001483:Base Sequence; D003001:Cloning, Molecular; D003429:Cross Reactions; D004269:DNA, Bacterial / Q000235:genetics; D004195:Disease Models, Animal; D004697:Endocarditis, Bacterial / Q000276:immunology; D018604:Epitope Mapping; D006801:Humans; D016056:Immunodominant Epitopes / Q000235:genetics; D066298:In Vitro Techniques; D051379:Mice; D008969:Molecular Sequence Data; D018805:Sepsis / Q000276:immunology; D013045:Species Specificity; D013290:Streptococcal Infections / Q000276:immunology* / Q000517:prevention & control; D013291:Streptococcus / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics / Q000494:pharmacology
chemical_list: D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D004269:DNA, Bacterial; D016056:Immunodominant Epitopes; D014614:Vaccines, Synthetic